Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose Chemotherapy with Stem Cell Rescue in Poor Prognosis Breast Cancer
NCT00002509Phase 2Completed
- Sponsor
- Temple University
- Start
- Nov 1991
- Primary completion
- Dec 2003
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cyclophosphamide, etoposide and carboplatin in breast cancer, sponsored by Temple University. Started Nov 1991; status: completed.
02
Drugs
cyclophosphamideetoposidecarboplatin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00002509.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002509.